Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ovarian Aging in Women Newly Diagnosed With Low Grade Glioma Treated With Temozolomide (Temodar®)

NCT01452854 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01452854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01452854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ovarian Aging in Women Newly Diagnosed With Low Grade Glioma Treated With Temozolomide (Temodar®)
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Terminated
Start date
October 31, 2011
Completion date
November 30, 2013
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low grade glioma